199 related articles for article (PubMed ID: 2553825)
1. Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection.
Kohl S; West MS; Prober CG; Sullender WM; Loo LS; Arvin AM
J Infect Dis; 1989 Nov; 160(5):770-6. PubMed ID: 2553825
[TBL] [Abstract][Full Text] [Related]
2. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
Kohl S
Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.
Kohl S; Strynadka NC; Hodges RS; Pereira L
J Clin Invest; 1990 Jul; 86(1):273-8. PubMed ID: 2164044
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
5. Murine Model of Maternal Immunization Demonstrates Protective Role for Antibodies That Mediate Antibody-Dependent Cellular Cytotoxicity in Protecting Neonates From Herpes Simplex Virus Type 1 and Type 2.
Kao CM; Goymer J; Loh LN; Mahant A; Burn Aschner C; Herold BC
J Infect Dis; 2020 Feb; 221(5):729-738. PubMed ID: 31599942
[TBL] [Abstract][Full Text] [Related]
6. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
7. The natural history of herpes simplex virus infection of mother and newborn.
Whitley RJ; Nahmias AJ; Visintine AM; Fleming CL; Alford CA
Pediatrics; 1980 Oct; 66(4):489-94. PubMed ID: 6253866
[TBL] [Abstract][Full Text] [Related]
8. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex.
Kohl S; Shaban SS; Starr SE; Wood PA; Nahmias AJ
J Pediatr; 1978 Aug; 93(2):206-10. PubMed ID: 671153
[TBL] [Abstract][Full Text] [Related]
9. Relationship of antibody to outcome in neonatal herpes simplex virus infections.
Yeager AS; Arvin AM; Urbani LJ; Kemp JA
Infect Immun; 1980 Aug; 29(2):532-8. PubMed ID: 7216423
[TBL] [Abstract][Full Text] [Related]
10. Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection.
Arvin AM
Rev Infect Dis; 1991; 13 Suppl 11():S953-6. PubMed ID: 1664133
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibody to herpes simplex in pregnant women and their neonates.
Harger JH; Guevarra L; Armstrong JA
J Perinatol; 1990 Mar; 10(1):16-9. PubMed ID: 2156030
[TBL] [Abstract][Full Text] [Related]
12. Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease.
Jiang Y; Patel CD; Manivanh R; North B; Backes IM; Posner DA; Gilli F; Pachner AR; Nguyen LN; Leib DA
mBio; 2017 Jul; 8(4):. PubMed ID: 28679745
[TBL] [Abstract][Full Text] [Related]
13. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.
Sullender WM; Yasukawa LL; Schwartz M; Pereira L; Hensleigh PA; Prober CG; Arvin AM
J Infect Dis; 1988 Jan; 157(1):164-71. PubMed ID: 2826604
[TBL] [Abstract][Full Text] [Related]
14. The relative role of transplacental and milk immune transfer in protection against lethal neonatal herpes simplex virus infection in mice.
Kohl S; Loo LS
J Infect Dis; 1984 Jan; 149(1):38-42. PubMed ID: 6319505
[TBL] [Abstract][Full Text] [Related]
15. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
[TBL] [Abstract][Full Text] [Related]
16. The effect of route of delivery on neonatal natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
Frazier JP; Kohl S; Pickering LK; Loo LS
Pediatr Res; 1982 Jul; 16(7):558-60. PubMed ID: 6287398
[TBL] [Abstract][Full Text] [Related]
17. A comparison of herpes simplex virus specific antibodies found in human milk and serum.
Liu A; Sanchez-Pescador L; Ruiz-Palacios G; Morrow AL; Pickering LK; Kohl S
Pediatr Res; 1992 Jun; 31(6):591-5. PubMed ID: 1321972
[TBL] [Abstract][Full Text] [Related]
18. Defective production of antibody to herpes simplex virus in neonates: defective production of T helper lymphokine and induction of suppression.
Kohl S; Cox PA; Loo LS
J Infect Dis; 1987 Jun; 155(6):1179-87. PubMed ID: 3033093
[TBL] [Abstract][Full Text] [Related]
19. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity.
Patel CD; Backes IM; Taylor SA; Jiang Y; Marchant A; Pesola JM; Coen DM; Knipe DM; Ackerman ME; Leib DA
Sci Transl Med; 2019 Apr; 11(487):. PubMed ID: 30971454
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.
Ashley RL; Dalessio J; Burchett S; Brown Z; Berry S; Mohan K; Corey L
J Clin Invest; 1992 Aug; 90(2):511-4. PubMed ID: 1322941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
